What is the latest status of the project “Granules II”?

The status recorded for “Granules II” is completed.

Who are the main government, EPC, and private stakeholders for “Granules II”?

Taiyo maps the stakeholders of “Granules II”: government bodies (International Finance Corporation (IFC)).

What is the budget and commercial profile for the project “Granules II”?

The procurement structure is Public-Private Partnership (PPP).

Where can I verify the source and access all details for “Granules II”?

This Taiyo project page references International Finance Corporation (IFC) along with the original URL (https://disclosures.ifc.org/project-detail/ESRS/31253/granules-ii). Taiyo standardizes official data into a consistent, searchable project profile.

Granules II

Sector: Warehouse • Location: India

Source: International Finance Corporation (IFC)

Project

Completed

Granules - an existing IFC client - is a leading Contract Manufacturing Organization supplying high volume Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Formulation Intermediates (PFIs) to the bulk over-the-counter (OTC) drugs industry in the US, Europe, Latin America, Australia and India. Granules has three wholly-owned manufacturing plants near Hyderabad in India (Jeedimetla, Bonth

Project Information

5 Q

The project “Granules II” is an infrastructure initiative in the Warehouse sector, located in India. Taiyo aggregates data on it from International Finance Corporation (IFC).

Want to explore the full details? View the full report

Participants

Sponsoring Agency	Obfuscated Data
Company	Obfuscated Data

Status

Original status	completed
Taiyo status	Obfuscated Data
Taiyo last update	00-00-0000
Available timestamps	00-00-0000
Available timestamp type	Obfuscated Data

Contact

Contact name	Obfuscated Data
Phone	0000000000
Email	ObfuscatedData@email.com
Address	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description	Granules - an existing IFC client - is a leading Contract Manufacturing Organization supplying high volume Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Formulation Intermediates (PFIs) to the bulk over-the-counter (OTC) drugs industry in the US, Europe, Latin America, Australia and India. Granules has three wholly-owned manufacturing plants near Hyderabad in India (Jeedimetla, Bonthapally and Gagillapur) and one plant in China through a 50:50 joint venture. The company is undertaking an investment program at its Gagillapur facility comprising of: expanding the capacity of its multi-product tableting and PFI plants and its warehousing capacity with automated storage systems (the “Project”). Granules is in compliance with all the E&S related requirements including the action plan developed for the previous IFC investments. The information about these previous investments can be found under project # 28199 (http://www.ifc.org/ifcext/spiwebsite1.nsf/1ca07340e47a35cd85256efb00700cee/4EDA7709DA6A618F85257597007AD9C3), and #25947 (http://www.ifc.org/ifcext/spiwebsite1.nsf/0/5B337ECFAB7EE746852576BA000E29F6).
Original sub-sector	Obfuscated
Original Currency	USD
Original budget	000000000000000
Procurement method	Obfuscated Data
Budget	000000000000000

Location

Region	Obfuscated
Country	Obfuscated
State	Obfuscated Data
County	Obfuscated
Location	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability	High
Data quality score	100%
Source	Obfuscated Data
URL	obfuscated_data,obfuscateddata.com

More Details

Project Type	Obfuscated Data
Article Published Date	Obfuscated Data

Granules II

Project Information FAQ

Project Information

More Warehouse projects in India